These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 84261)

  • 1. Fracturing dialysis osteodystrophy and dialysis encephalopathy. An epidemiological survey.
    Parkinson IS; Ward MK; Feest TG; Fawcett RW; Kerr DN
    Lancet; 1979 Feb; 1(8113):406-9. PubMed ID: 84261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteomalacic dialysis osteodystrophy: Evidence for a water-borne aetiological agent, probably aluminium.
    Ward MK; Feest TG; Ellis HA; Parkinson IS; Kerr DN
    Lancet; 1978 Apr; 1(8069):841-5. PubMed ID: 76795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
    Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
    Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
    [No Abstract]   [Full Text] [Related]  

  • 4. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
    Wills MR; Savory J
    Lancet; 1983 Jul; 2(8340):29-34. PubMed ID: 6134894
    [No Abstract]   [Full Text] [Related]  

  • 5. [Water purification in dialysis treatment. Aluminum and encephalopathy].
    Hagstam KE; Lindergård B; Lindholm T; Thysell H
    Lakartidningen; 1980 Jun; 77(26-27):2425-7. PubMed ID: 7401791
    [No Abstract]   [Full Text] [Related]  

  • 6. Aluminum and renal osteodystrophy.
    Nebeker HG; Coburn JW
    Annu Rev Med; 1986; 37():79-95. PubMed ID: 3085581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of fracturing renal osteodystrophy by desferrioxamine.
    Ackrill P; Day JP; Garstang FM; Hodge KC; Metcalfe PJ; Benzo Z; Hill K; Ralston AJ; Ball J; Denton J
    Proc Eur Dial Transplant Assoc; 1983; 19():203-7. PubMed ID: 6878234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversible dialysis encephalopathy: role for aluminium-containing gels.
    Masselot JP; Adhemar JP; Jaudon MC; Kleinknecht D; Galli A
    Lancet; 1978 Dec 23-30; 2(8104-5):1386-7. PubMed ID: 82892
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of water deionisers on 'fracturing osteodystrophy' and dialysis encephalopathy in Plymouth.
    Leather HM; Lewin IG; Calder E; Braybrooke J; Cox RR
    Nephron; 1981; 29(1-2):80-4. PubMed ID: 7329479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The role of aluminum in the human body].
    Strzałkowska D
    Postepy Hig Med Dosw; 1991; 45(3-4):257-79. PubMed ID: 1946095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dialysis encephalopathy, bone disease and anaemia: the aluminum intoxication syndrome during regular haemodialysis.
    Parkinson IS; Ward MK; Kerr DN
    J Clin Pathol; 1981 Nov; 34(11):1285-94. PubMed ID: 7320226
    [No Abstract]   [Full Text] [Related]  

  • 12. Dialysate aluminium concentration and renal bone disease.
    Walker GS; Aaron JE; Peacock M; Robinson PJ; Davison AM
    Kidney Int; 1982 Feb; 21(2):411-5. PubMed ID: 7070002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Renal osteodystrophy in Maracaibo].
    Salgado O; García R; Delling G; Navarro J; Romero RA; Rodríguez-Iturbe B
    Invest Clin; 1992; 33(4):153-64. PubMed ID: 1303675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aluminum toxicity in relation to kidney disorders.
    King SW; Savory J; Wills MR
    Ann Clin Lab Sci; 1981; 11(4):337-42. PubMed ID: 7023347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum: culprit or accessory in the genesis of renal osteodystrophy.
    Quarles LD; Gitelman HJ; Drezner MK
    Semin Nephrol; 1986 Mar; 6(1):90-101. PubMed ID: 3299578
    [No Abstract]   [Full Text] [Related]  

  • 16. Reversal of aluminium dialysis encephalopathy after desferrioxamine treatment.
    Arze RS; Parkinson IS; Cartlidge NE; Britton P; Ward MK
    Lancet; 1981 Nov; 2(8255):1116. PubMed ID: 6118567
    [No Abstract]   [Full Text] [Related]  

  • 17. Water content of aluminum, dialysis dementia, and osteomalacia.
    Wills MR; Savory J
    Environ Health Perspect; 1985 Nov; 63():141-7. PubMed ID: 3908086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two forerunners of the encephalopathy of hemodialysed patients : osteomalacic osteodystrophy and electroencephalographic alterations. Influence of the aluminium concentration in the dialysis fluid (author's transl)].
    Vecchierini-Blineau MF; Thébaud HE; Brochard D; Coville P
    Nephrologie; 1980; 1(1):29-32. PubMed ID: 7301017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialysis encephalopathy.
    Alfrey AC
    Kidney Int Suppl; 1986 Feb; 18():S53-7. PubMed ID: 3457997
    [No Abstract]   [Full Text] [Related]  

  • 20. Aluminum associated bone disease: clinico-pathologic correlation.
    Ihle B; Buchanan M; Stevens B; Marshal A; Plomley R; d'Apice A; Kincaid-Smith P
    Am J Kidney Dis; 1982 Sep; 2(2):255-63. PubMed ID: 7124722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.